The successful candidate will break news on an industry that has suffered a major political loss in the United States and is bracing for new federal efforts to bring down the cost of prescription medicines.
This reporter would shed light on the commercial strategies of leading industry players, with a broad view on how new medicines in development will impact companies, investors, patients and providers.
At the same time, the candidate will report on how big pharma companies are turning to deals and new business opportunities after having benefited tremendously from developing vaccines and treatments critical to alleviating the COVID-19 pandemic.
The reporter would demonstrate a track record of deep source development and show how they would cultivate a roster of sources among pharmaceutical and biotech executives, government health officials and industry investors. The preferred location for the role is New York.
About the Role
As our U.S. Pharmaceutical Industry Reporter, you will:
About You
To be our U.S. Pharmaceutical Industry Reporter, you will likely have:
Please note, the deadline for applications is Friday 14th October 2022.
To apply, go here.
Former Business Insider executive editor Rebecca Harrington has been hired by Dynamo to be its…
Bloomberg Television has hired Brenda Kerubo as a desk producer in London. She will be covering Europe's…
In a meeting at CNBC headquarters Thursday afternoon, incoming boss Mark Lazarus presented a bullish…
Ritika Gupta, the BBC's North American business correspondent, was interviewed by Global Woman magazine about…
Rest of World has hired Kinling Lo as a China reporter. Lo was previously a…
Bloomberg News saw strong unique visitor growth to its website in October, passing Fox Business…